Skip to main content
TipRanks
Go Ultimate75% OFF

Virax Biolabs Group Ltd. Class A (VRAX) Stock Price & Analysis

170 Followers

VRAX Stock Chart & Stats

$0.38-$0.05(-11.40%)
At close: 4:00 PM EST
$1$2$3Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
$0.29 - $0.46
52-Week Range
$0.29 - $21.75
Previous Close
$0.43
Volume
N/A
Average Volume (3M)
610.09K
Market Cap
$512.44K
Enterprise Value
-$2.07T
Total Cash (Recent Filing)
$6.52M
Total Debt (Recent Filing)
$414.39K
Price to Earnings (P/E)
―
Beta
2.19
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Virax Biolabs Group Ltd. Class A News

VRAX FAQ

What was Virax Biolabs Group Ltd. Class A’s price range in the past 12 months?
Virax Biolabs Group Ltd. Class A lowest stock price was $0.29 and its highest was $21.75 in the past 12 months.
What is Virax Biolabs Group Ltd. Class A’s market cap?
Virax Biolabs Group Ltd. Class A’s market cap is $512.44K.
When is Virax Biolabs Group Ltd. Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Virax Biolabs Group Ltd. Class A’s earnings last quarter?
Virax Biolabs Group Ltd. Class A released its earnings results on Feb 02, 2023. The company reported -$30.945 earnings per share for the quarter.
Is Virax Biolabs Group Ltd. Class A overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Virax Biolabs Group Ltd. Class A pay dividends?
Virax Biolabs Group Ltd. Class A does not currently pay dividends.
What is Virax Biolabs Group Ltd. Class A’s EPS estimate?
Virax Biolabs Group Ltd. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virax Biolabs Group Ltd. Class A have?
Virax Biolabs Group Ltd. Class A has 1,344,988 shares outstanding.
What happened to Virax Biolabs Group Ltd. Class A’s price movement after its last earnings report?
Virax Biolabs Group Ltd. Class A reported an EPS of -$30.945 in its last earnings report. Following the earnings report the stock price went up 6.892%.
Which hedge fund is a major shareholder of Virax Biolabs Group Ltd. Class A?
Currently, no hedge funds are holding shares in VRAX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology